5074 Bacterial light-harvesting complex subunits
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Lipids and lipid-like molecules | 51 | 5.6 | 9.11× | q < 0.0001 | |
| Organoheterocyclic compounds | 46 | 7.7 | 5.94× | q < 0.0001 | |
| Homogeneous metal compounds | 9 | 24.7 | 0.36× | q < 0.0001 | |
| Homogeneous non-metal compounds | 0 | 10.8 | 0 | q < 0.0001 | |
| Nucleosides, nucleotides, and analogues | 0 | 13.9 | 0 | q < 0.0001 | |
| Organic acids and derivatives | 0 | 7.8 | 0 | q = 8.7e-4 | |
| Organic oxygen compounds | 0 | 10.0 | 0 | q < 0.0001 | |
| Hydrocarbons | 3 | 0.4 | 8.54× | not tested | |
| Organic nitrogen compounds | 3 | 1.6 | 1.87× | not tested | |
| Benzenoids | 1 | 3.7 | 0.27× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01853 | BCL | Bacteriochlorophyll A | 1,560 |
| DB11231 | LYC | Lycopene | 138 |
| DB03429 | CDL | Tetrastearoyl cardiolipin | 101 |
| DB09270 | U10 | Ubidecarenone | 45 |
| DB01728 | PEF | 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine | 36 |
| DB07646 | DET | UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE | 10 |
| DB04079 | HTO | Heptane-1,2,3-Triol | 8 |
| DB03317 | HEC | Ferroheme C | 3 |
| DB04327 | PEE | Phosphatidylethanolamine | 3 |
| DB08231 | MYR | Myristic acid | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| BCL | BACTERIOCHLOROPHYLL A | 2,725 |
| CRT | SPIRILLOXANTHIN | 811 |
| SPO | SPHEROIDENE | 515 |
| V7N | (2~{E},4~{E},6~{E},10~{E},12~{E},14~{E},16~{E},18~{E},20~{E},22~{Z},24~{E},26~{E},28~{E})-23-methanoyl-31-methoxy-2,6,10,14,19,27,31-heptamethyl-dotriaconta-2,4,6,10,12,14,16,18,20,22,24,26,28-tridecaenoic acid | 480 |
| CAmetal | CALCIUM ION | 323 |
| PGV | (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE | 291 |
| CDL | CARDIOLIPIN | 149 |
| LYC | LYCOPENE | 144 |
| KGD | beta,psi-caroten-4-one | 132 |
| 0V9 | (19R,22S)-25-amino-22-hydroxy-22-oxido-16-oxo-17,21,23-trioxa-22lambda~5~-phosphapentacosan-19-yl (9Z)-hexadec-9-enoate | 130 |
| 07D | Trans-Geranyl BACTERIOCHLOROPHYLL A | 126 |
| A1EFU | (4~{E},16~{E},26~{E})-2-methoxy-2,6,10,14,19,23,27,31-octamethyl-dotriaconta-4,6,8,10,12,14,16,18,20,22,26,30-dodecaen-3-one | 102 |
| PEX | 1,2-DIDECANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE | 77 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 72 |
| IRM | 1,2-Dihydro-psi,psi-caroten-1-ol | 63 |
| U4Z | gamma-Carotene | 63 |
| SP2 | 3,4-DIHYDROSPHEROIDENE | 54 |
| U10 | UBIQUINONE-10 | 52 |
| UNL | Unknown ligand | 52 |
| BCB | BACTERIOCHLOROPHYLL B | 51 |